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Abstract Microglia are the resident mononuclear phagocytes of the central nervous system and have been implicated in the pathogenesis of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS). During neurodegeneration, microglial activation is accompanied by infiltration of circulating monocytes, leading to production of multiple inflammatory mediators in the spinal cord. Degenerative alterations in mononuclear phagocytes are commonly observed during neurodegenerative diseases, yet little is known concerning the mechanisms leading to their degeneration, or the consequences on disease progression. Here we observed that the serotonin 2B receptor (5-HT 2B ), a serotonin receptor expressed in microglia, is upregulated in the spinal cord of three different transgenic mouse models of ALS. In mutant SOD1 mice, this upregulation was Electronic supplementary material The online version of this article (doi:10.1007/s00401-016-1534-4) contains supplementary material, which is available to authorized users.
Introduction
Amyotrophic lateral sclerosis (ALS) is the major adult onset motor neuron disease with a lifetime risk of 1/400, and represents the third most frequent neurodegenerative disease after Alzheimer's and Parkinson's diseases. ALS is characterized by the selective degeneration of upper motor neurons in the cerebral cortex and lower motor neurons in spinal cord and brainstem, and leads to progressive paralysis and death within 3-5 years after onset [41] . A number of ALS cases are dominantly inherited and more than 20 genes have been associated with ALS, in particular C9ORF72, TARDBP, FUS and SOD1 [48] . Most experimental research has involved expression of mutant SOD1 in transgenic mice, leading to development of typical ALS symptoms.
In recent years it has become increasingly clear that progression of ALS symptoms is not caused exclusively by intrinsic events within motoneurons, but rather involves many other cell types [4, 57] . In particular, mononuclear phagocytes, that collectively refers to both microglia and infiltrating monocytes [23, 28, 34, 40] , are activated during ALS [57, 58, 75] . This activation is characterized by appearance of an amoeboid morphology, increased phagocytic activity and production of a number of cytokines and chemokines [52, 75] . Activation of mononuclear phagocytes could either be protective by providing support to neurons and astrocytes in response to injury and by cleaning debris through phagocytosis or deleterious by creating an inflammatory environment contributing to neuronal degeneration [51, 57] . Importantly, decreased expression of mutant SOD1 in CD11b-positive cells, i.e. in all mononuclear phagocytes, prolongs disease progression suggesting that mutant SOD1 exerts toxic action in these cells thereby accelerating disease [5] . Furthermore, decreased activation of the pro-inflammatory transcription factor NF-kappaB in microglial cells potently slowed down disease progression [26] . Mononuclear phagocytes appear themselves affected during disease progression. Indeed, the recently identified molecular signature of homeostatic microglia [7] [8] [9] 12 ] is heavily altered during disease progression in ALS [7, 12] . This loss of typical microglial expression patterns could be directly correlated with degeneration of mononuclear phagocytes, documented in different neurodegenerative diseases [62, 63, 74 ] including a transgenic model of ALS [25, 63] . Whether mononuclear phagocytes degeneration is microglia specific or also occurs in infiltrating monocytes, and whether this degeneration might be involved in neurodegeneration is not known.
Recently, we observed that serotonin 2B receptor (5-HT 2B R) mRNA levels were strongly upregulated in the spinal cord of a mouse model of ALS-SOD1(G86R) mice, notably at later stages and coincident with development of spasticity [15] . 5-HT 2B R is expressed in microglia in the CNS, with expression in a few other cell types such as brain serotonin neurons [16] . In human peripheral macrophages, 5-HT 2B R mediates the response to serotonin by skewing macrophages to a M2, anti-inflammatory, phenotype [14] . More relevant to ALS, we showed that 5-HT 2B R is the major serotonin receptor expressed on perinatal microglia and regulates chemotaxis of microglial processes in response to serotonin [44] . These findings raise the possibility that the observed 5-HT 2B R upregulation could be linked to microglial activation and function in the pathogenesis of ALS.
Here, we show that the lack of 5-HT 2B R is associated with degeneration of spinal cord mononuclear phagocytes in ALS mouse models and human patients, and slows down disease progression of ALS. This has broad consequences for our understanding of serotonin function during disease, and provides a plausible pharmacological target to modulate neuroinflammation in ALS and other neurodegenerative diseases.
Materials and methods

Patients
Two independent populations of patients were studied here. In the human genetic study, cases from the Netherlands were diagnosed with probable or definite ALS according to the revised El-Escorial Criteria by neurologists specialized in motor neuron diseases [6] . Tertiary referral centers for ALS were University Medical Center Utrecht, Academic Medical Centre Amsterdam and Radboud University Medical Center Nijmegen. All participants gave written informed consent, and approval was obtained from the relevant local ethical committees for medical research. Characteristics of ALS patients included in this genetic study are presented in Table S1 . Control individuals were free of any neuromuscular disease and matched for age, gender and ethnicity ascertained through a population based study on ALS in the Netherlands [35] . Patients included in the neuropathology study were from Ulm University. All autopsy brains were collected in
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accordance with local ethical committee guidelines and the federal law governing the use of human tissue for research in Germany. The characteristics of these patients are described in Table S2 .
Animals
Transgenic mice were housed in the animal facility of the medicine faculty of Strasbourg University, with 12 h/12 h of light/dark and unrestricted access to food and water. In all experiments, littermates were used for comparison, and mice compared are thus in the same genetic background. Transgenic mice carrying SOD1 G86R mutation [18] and their non-transgenic littermates on a FVB/N background were genotyped and onset of symptoms was defined according to previous studies [15] . Dynactin mice expressing G59S mutation of P150 Glued have been previously described [47] , and were used according to previous studies [72] . SOD1(G37R) mice were kindly provided by Dr Don W. Cleveland and have been described previously [5] .
Htr2b
−/− mice in a 129S2/Sv PAS background have been described previously [49, 53] . All animal experimentation was performed in accordance with institutional guidelines, and protocols were approved by the local ethical committee from Strasbourg University (CREMEAS) under number AL/30/37/02/13 and AL/29/36/02/13 in accordance with European regulations.
Mouse breeding, survival and motor phenotyping
SOD1 (G86R) mice were crossed with Htr2b
−/− mice to obtain the F1 generation. Male Htr2b +/− carrying SOD1 (G86R) transgene were then crossed with female Htr2b +/− from the F1 generation to obtain the F2 generation with the genotypes of interest. Htr2b −/− mice carrying SOD1 (G86R) transgene (n = 16) were compared with littermate Htr2b +/+ mice carrying SOD1 (G86R) transgene (n = 12), Htr2b +/− mice carrying SOD1 (G86R) transgene (n = 19), and Htr2b −/− or Htr2b +/+ littermate mice negative for SOD1 (G86R) transgene were used as control.
Mice were visually inspected daily and weekly monitored for body weight and motor symptoms from 4 weeks of age until end stage of the disease. To evaluate muscle strength, we used a gripmeter test (Bioseb, ALG01; France). Disease course and survival were assessed daily by visual inspection. The muscle force was averaged as the mean of three consecutive trials per session. Disease onset was calculated as time of peak of body weight. Disease duration was the time between the peak of body weight and death. After disease onset mice were followed daily and end stage was defined by full paralysis and when mice were unable to return after 10 s placed on the back. End stage mice were immediately euthanized.
Histological techniques
Muscle tissues and spinal cords were dissected and fixed by immersion in 4 % paraformaldehyde in 0.1 M phosphate buffer pH 7.4 overnight. The whole muscles were dissected into fibre bundles, stained using α-Bungarotoxin labeled with tetramethylrhodamine(Sigma, T195; 1:500) for nicotinic acetylcholine receptors (AchRs), anti-synaptophysin (Millipore, 5258; 1:250) and anti-neurofilament (Abcam, Ab24574, 1/100) for pre-synaptic elements, followed by fluorescent secondary antibodies anti-mouse Alexa 488 (Life Technologies, A11001), and Draq 5 for nuclei (Cell Signaling, 4084; 1:1000). Single-layer images or merged Z-Stack images (1 µm optical section, for 10 µm thickness of merged z-stacks) were acquired using a laser-scanning microscope (confocal Leica SP5 Leica Microsystems CMS GmbH) equipped with 63× oil objective (NA1.4). Excitation wavelengths were sequentially argon laser 488 nm, diode 561 nm, and helium neon laser 633 nm. Emission bandwidths are 500-550 nm for Alexa488, 570-620 nm for Alexa594, and 650-750 nm for draq5.
The lumbar parts of spinal cords were dissected and the L3-L5 region was identified according to previous studies [29] . Tissue was cryoprotected in 30 % sucrose and snap frozen in melting isopropanol in TissueTek (O.C.T.Compound, SAKURA#4583). Cryosections (Leica CM 3050S) of 16 µm were obtained for histological analysis of end stage mice (10 sections per animal). Spinal cord sections were incubated in phosphate buffered saline (PBS) 0.1 % Triton with anti-choline acetyl transferase (ChAT) (Millipore, AB144-P; diluted 1:50) for motor neuron quantification and anti-Iba1 (Abcam ab5076, 1/100) antibody followed by biotinylated species-specific secondary antibody. The staining was revealed using the ABC kit (Vectastain), by the avidin-biotin complex immunoperoxidase technique or immunofluorescence. Identical techniques and antibodies were used to stain paraffin sections of ALS patients for Iba1 immunostaining.
Quantification of histological results
Motoneuron counting was performed in L3-L5 ventral horn in every tenth section for ten sections in total per animal (160 µm thick in total, spread over 1.6 mm). Only ChAT + neurons located in a position congruent with that of motoneuron groups were counted [13] . All ChAT + profiles located in the ventral horns of immunostained sections and clearly displayed in the plane of section were counted. Total estimated motoneuron numbers were obtained using a computer-assisted microscope (Nikon Eclipse E800) and associated software (Nis Elements version 4.0). Total numbers of motoneurons and the mean area of individual cells were obtained using ImageJ freeware (http://rsbweb. nih.gov/ij/) after image acquisition at 20X under the same exposition parameters with a digital camera (Nikon Digital Sight DS-U3) [61] . The observer was blinded to the genotype of studied mice.
To quantify ventral horn atrophy, the total surface of the ventral horn was measured using Nis Elements version 4.0.
For staining of mononuclear phagocytes, measurement of Iba1 immunoreactivity was performed on images acquired from Iba1 immunostaining at 10× magnification. A standardized rectangle was drawn in the ventral horn and the surface of Iba1 staining relative to background was calculated using the Pixel classifier algorithm of Nikon Nis-element 3.10 SP3 software, using the intensity profile measurement function. The observer was blinded to the genotype of studied mice. >10 images per animal were quantified, with n = 5 animals per genotype.
Iba1 positive cells morphology was defined according to previous work [63] : (i) resting phagocyte with small branched cellular processes and small cell soma, (ii) activated state with greater distal arborization, (iii) phagocytic state with increased cell soma size, and (iv) dystrophic state with fragmented cytoplasm. Iba1-immunopositive cells were categorized according to their state in each ventral horn section of the spinal cord by an observer blinded to the genotype (HEO). Percentage of each state was then calculated for each genotype of interest.
To quantify degeneration of Iba1 positive cells in ALS patients, an observer blinded to the genotype scored from 0 to 4 the occurrence of degeneration in 2-5 sections per patient, with a score of 0 for sections showing non-degenerating phagocytes. Features of microglial degeneration were according to Streit and collaborators [63] . Similar results were obtained by two independent blinded observers (HEO and LD).
Isolation of CD11b positive cells
Isolated spinal cords and brain stems from end stage SOD1 (G86R) mice were transferred into a 2 ml sterile tube with 1 ml of Hank's balanced salt solution (HBSS) (Invitrogen), then triturated to single-cell suspension using Miltenyi's Neural Tissue Dissociation Kit (P) (Miltenyi Biotec). After a final wash in HBSS containing CaCl 2 and MgCl 2 , the cell suspension was incubated with anti-myelin magnetic microbeads using Myelin removal kit (Miltenyi Biotec). The cell suspension was passed onto LS columns (Miltenyi Biotec) exposed to a strong magnetic field. The flow through (demyelinated cells) was incubated with antiCD11b magnetic microbeads using CD11b kit (Miltenyi Biotec). The cell suspension was passed onto LS columns (Miltenyi Biotec) exposed to a strong magnetic field. The flow through (non-CD11b cells) was subsequently used as a negative control and the suspension obtained once the magnetic field was switched off (CD11b cells) used as a positive fraction. Both fractions were used for gene expression analysis.
Real-time quantitative polymerase chain reaction
Total RNA was extracted from the spinal cord and the brain stem of end stage mice using TRIzol (Invitrogen). RNA was reverse transcribed using 1 µg of RNA and the iScript cDNA synthesis kit (BioRad). We performed realtime PCR using IQ SYBR green Supermix (BioRad) and data were normalized with GeNorm software [69] using two standard genes (Tata-box binding protein, and RNA polymerase 2 subunit). For microglia experiments total RNA was extracted by using RNeasy Micro Kit (Qiagen), RNA was reverse transcribed using 1 µg of RNA and the iScript cDNA synthesis kit. Quantitative PCR was performed on a CFX96 Real-time System (BioRad) using iQ SYBR Green supermix (BioRad). Relative mRNA levels were calculated with BioRad CFX Manager 3.1 using ΔΔC t method.
Primer sequences are provided in Table S3 .
Echocardiography
Animals were analyzed for cardiac anatomy and function on a Sonos 5500 (Hewlett Packard, USA) with a 15 MHz linear transducer (15L6). All the examinations were performed in mice anesthetized with 1-1.5 % isoflurane. The heart was first imaged in the two-dimensional (2D) mode in the parasternal long-axis view to obtain the aortic root dimensions. The aortic flow velocity and the heart rate (HR) were measured with pulsed-wave Doppler on the same section. The cardiac output (CO) was calculated from the following equation: CO = 0.785 × D2 × VTI × HR where D is the diameter of the aortic root and VTI is the velocity-time integral of the Doppler aortic spectrum. Left ventricular cross sectional internal diameters in end-diastole (EDLVD) and end-systole (ESLVD) were obtained by an M-mode analysis of a 2D-short axis view at the papillary muscle level. The shortening fraction was calculated as SF = (EDLVD-ESLVD/EDLVD) × 100. From this view, the diastolic septum (SW) and posterior wall (PW) thicknesses were measured. The left ventricular mass (LVM) was calculated with the following formula:
. All the measurements were performed on at least three beats, according to the guidelines of the American Society of Echocardiography.
Microglial culture
Mouse microglial cells in primary culture were prepared as described previously [73] . Briefly, 1-5 day old C57Bl/6 mice were decapitated according to the guidelines of the animal research center of Ulm University, Ulm, Germany. Meninges were removed from the brains. Neopallia were dissected and dissociated by enzyme treatment (1 % trypsin, Invitrogen, 0.05 % DNAse, Worthington, 2 min) and then mechanically dissociated. The cells were centrifuged (200×g, 10 min), suspended in Dulbecco's modified Eagle's medium (DMEM, Invitrogen) supplemented with penicillin (100 U/ml), streptomycin (100 µg/ml) (Invitrogen) and 10 % heat-inactivated fetal bovine serum (FBS, PAA), and plated into 75-cm 2 flasks (BD Falcon) pre-coated with 1μg/ml poly-l-ornithine (Sigma). Cells from the neopallia of two brains were plated at 10 ml per flask. After 3 days, adherent cells were washed three times with Dulbecco's phosphate buffered saline (DPBS) (Invitrogen) and incubated with serum-supplemented culture media. After 7-14 days in culture, floating and loosely attached microglial cells were manually shaken off, centrifuged (200×g, 10 min) and seeded into 96-well plates or 6-well plates (PRIMARIA, BD Falkon) at a density of 4 × 10 4 or 6 × 10 5 cells/well, respectively, in DMEM without serum (Invitrogen) supplemented with penicillin (100 U/ml), streptomycin (100 µg/ml) (Invitrogen) and Glutamax (Invitrogen). Cells in the flasks were reincubated with serum-supplemented media after shaking. Repopulating microglial cells were removed every 3-4 days for a total of 3 weeks until fewer microglial cells were observed.
LDH and WST-1 assays
The lactate dehydrogenase (LDH) assay and water soluble tetrazolium salt (WST-1) assay were performed as described in the manual for the LDH-Cytotoxicity Assay Kit (Bio Vision) and the WST-1 Assay Kit (Quick Cell Proliferation Assay Kit; BioVision). For a positive cell death control, microglia were treated with 1 % Triton-X100 (Sigma) for 30 min. Results were expressed as a percentage of Triton treatment, with 0 % being untreated control.
HTR2B Polymorphisms in human ALS
In total 1923 cases and 2881 controls were genotyped on two different platforms; IlluminaOmniExpress (n = 3488) and Illumina2.5 M (n = 1316). Extensive quality control using standard procedures was performed as described [68] . Following this, 612,666 SNPs and 3344 individuals (1207 cases and 2137 controls) were retained on the IlluminaOmniExpress chip, and the Illumina 2.5 M chip yielded 1,481,461 single nucleotide polymorphisms (SNPs) and 1294 individuals (679 cases and 615 controls). After this extensive quality control, seven HTR2B SNPs were extracted and used for analyses.
Statistical analysis
All data are presented as mean ± standard error of the mean.
When the measured values were not detectable in some of the experimental points (Fig. 1) , these values were considered to be null. Comparison of discrete values for two groups (Figs. 1, 2d , e, 8b, c) was performed using Student's t test. Comparison of discrete values for more than two groups (Figs. 3d, e, 4a, c, d , 5c, 6a, 7) was performed using One Way ANOVA followed by Tukey's post hoc test. Differences in survival or disease onset of animals ( Fig. 2a-c) was evaluated using log rank (Mantel Cox) test. To test for the effect of dose of Htr2b ablation, a log rank test for trend was performed ( Figure S2 ). For repeated measures ( Figure  S1 ), a repeated measures two way ANOVA was performed to test for the effect of age and the effect of genotype.
These statistical analyses were performed using Prism 6 (GraphPad software).
All differences were considered significant at p < 0.05.
To investigate the association of these seven SNPs with ALS, a logistic regression was performed in PLINK, corrected for dataset and 2 principle components. These seven SNPs are strongly correlated (D′ = 1, and five out of seven SNPs have an R 2 between 0.7 and 1, with a minor allele frequency >0.4). Therefore the strongest correlated SNP was tested for association with survival (rs10199752). A Cox proportional hazards (coxph) regression model in R was performed with survival and death as time and event, respectively, genotype as predictor, and sex, age at onset, and site at onset as covariates. Patients with a maximum survival of 15 years were included in this analysis (n = 1677). This coxph regression was conducted using a dominant model, comparing a wildtype homozygous reference group versus a variant group (combined homozygous variant and heterozygous).
Results
5-HT 2B receptor upregulation during murine ALS
We first asked whether 5-HT 2B R upregulation is a general feature of ALS mouse models. For this, we measured mRNA levels of the gene encoding 5-HT 2B R (Htr2b), in spinal cord and brainstem of three different mouse models of ALS at a late stage of disease progression, i.e. when both hindlimbs were paralyzed. We used mice expressing the G86R SOD1 mutation in the murine gene (SOD1(G86R) mice), or the G37R mutation in the human gene [5] . Consistent with previous results [15] , levels of Htr2b mRNA were strongly upregulated in spinal cord of SOD1(G86R) mice (Fig. 1a) but also of SOD1(G37R) mice (Fig. 1a) . Importantly, Htr2b mRNA upregulation was also observed in non-SOD1 ALS mouse models, in particular in the spinal cord of mice expressing the G59S mutation in the p150 subunit of dynactin [47] (Fig. 1a) . Last, Htr2b mRNA upregulation was also observed in the brainstem of SOD1(G86R) mice and p150(G59S) mice (Fig. 1b) . Thus, 5-HT 2B R mRNA is upregulated in various ALS mouse models.
The lack of 5-HT 2B receptor accelerates disease progression in mice
To determine the effect of 5-HT 2B R on motoneuron disease progression, we ablated the Htr2b gene in SOD1(G86R) mice. We crossed SOD1(G86R) mice with Htr2b −/− mice generated previously [53] . After two breeding steps, we obtained SOD1(G86R); Htr2b +/+ mice, SOD1(G86R) Htr2b +/− mice and SOD1(G86R); Htr2b −/− mice, that were followed longitudinally until death. These mice were in a mixed FVB/N x 129S2/Sv PAS background. Ablation of Htr2b led to reduction in body weight in SOD1(G86R) mice as compared to SOD1(G86R) mice expressing Htr2b (Fig. S1 ). Complete ablation of Htr2b shortened survival of SOD1(G86R) mice by 30 % (Fig. 2a-c) , while ablation of only one allele of Htr2b yielded an intermediate effect (p < 0.05, log rank test for trend, Fig. S2 ). Disease onset, as assessed either by peak of body weight [5] or by peak of grip strength, was not changed (Fig. 2a, b) . Indeed, ablation of Htr2b did not modify the age of peak weight as a measure of disease onset (Fig. 2d) , while drastically shortening disease duration after peak weight (Fig. 2e) .
Since 5-HT 2B R has been implicated in cardiac development and function [53, 55, 56] , we hypothesized that Htr2b ablation could affect cardiac function in SOD1(G86R) mice, leading to accelerated death. However, echocardiographic examinations did not show major reduction of cardiac contractility or output in SOD1(G86R); Htr2b −/− mice. In Fig. 2 The ablation of Htr2b in SOD1 (G86R) mice decreases life span and accelerates disease progression. Kaplan-Meier plot of disease onset, as determined by the peak weight (a) or the peak of grip strength (b), and of survival (c) for SOD1(G86R) mice wild type for Htr2b (red, n = 12) or knock-out for Htr2b (blue, n = 16). The mean of each group ± SEM is indicated on each panel. p < 0.05, log rank (Mantel-Cox) between Htr2b +/+ SOD1(G86R) mice and Htr2b−/−SOD1(G86R) mice in panel c. There were no significant difference (ns) in survival curves for panels a and b. The survival curve of SOD1 (G86R) mice in the original FVB/N background is indicated in dashed line. Duration of early disease (d, from birth to peak weight) and late disease (e, from peak weight to death) for SOD1(G86R) mice wild type for Htr2b (+/+, red) or knock-out for Htr2b (−/−, blue). p < 0.05, unpaired Student's t test particular, they did not exhibit echocardiographic signs of heart failure that could explain body weight loss (Fig. S3 ).
To determine whether SOD1(G86R); Htr2b −/− mice actually died of motoneuron disease, we examined neuromuscular junction histology in end-stage mice. All SOD1(G86R) mice examined at end-stage, irrespective of their Htr2b genotype, displayed heavily denervated neuromuscular junctions (Fig. 3a, b) . Consistent with this, SOD1(G86R); Htr2b +/+ mice displayed motoneuron degeneration similar to SOD1(G86R); Htr2b −/− mice (Fig. 3c, d ), and ventral horn atrophy was not modified by the Htr2b genotype (Fig.  S4 ). Motor neuron loss was similar in this mixed background to previous studies in the original FVB/N background [19, 20] . However, Htr2b ablation in SOD1(G86R) mice triggered atrophy of motoneuron cell bodies that was not present in SOD1(G86R); Htr2b +/+ mice (Fig. 3e) . Thus, consistent with its overexpression at symptom onset in SOD1(G86R) spinal cord [15] , the lack of 5-HT 2B R potently accelerates disease progression of SOD1(G86R) mice after onset.
5-HT2B receptor is upregulated in CD11b-positive cells and is required for activation of mononuclear phagocytes during ALS
Microgliosis occurs at symptom onset in brainstem and spinal cord of transgenic models of ALS [4, 5, 57] . Since 5-HT 2B R is expressed in microglia and peripheral M2 macrophages [14, 44] , increased 5-HT 2B R expression could reflect activation of microglia and/or of infiltrated monocytes. To address this question, we purified CD11b positive cells from late stage SOD1(G86R) mice using magnetic bead cell sorting, followed by RT-qPCR. To enable purification of CD11b positive cells from single individuals, we chose to pool brainstem and spinal cord from individual mice. Importantly, these areas are associated with strong microgliosis in mutant SOD1 models [25] . Using this procedure, we obtained CD11b positive fractions with a >300 fold enrichment in Iba1 mRNA, and corresponding 5-10 fold decrease in GFAP and ChAT mRNA content (Fig. S5) . Importantly, we observed that Htr2b upregulation was strictly limited to mRNA enriched from CD11b positive cells (Fig. 4a) . Activation of mononuclear phagocytes was reduced by Htr2b ablation, with decreased Iba1 staining in the spinal cord (Fig. 4b, c) . Consistently, the disease-elicited induction of multiple genes involved in neuroinflammatory responses was decreased in the brainstem of the same animals (Fig. 4d) . Interestingly, genes involved in the pro-inflammatory action of microglia (Fig. 4d, Nox2 , Ccl4, Mhc2), as well as genes involved in anti-inflammatory responses (Fig. 4d, Ym1, Dap12) showed similar blunted expression upon Htr2b ablation. Notably, Trem2-a cell surface receptor associated with neurodegeneration-was especially upregulated in SOD1(G86R); Htr2b −/− brainstem (Fig. 4d) . Thus, 5-HT 2B R is required for the activation of mononuclear phagocytes during motoneuron disease.
5-HT 2B receptor improves microglial survival
Searching for a role for 5-HT 2B R in mononuclear phagocytes, we re-examined the phenotype of these cells in SOD1(G86R); Htr2b −/− mice. We observed that spinal cord Iba1-positive cells of SOD1(G86R); Htr2b −/− mice frequently displayed Fig. 4 The ablation of Fig. 5a ). This was further confirmed on z-stacks of Iba1immunostained sections obtained using confocal microscopy ( Fig. 5b and Fig  S6) . Quantitative analysis demonstrated that about half of Iba1-positive cells displayed cytorrhexia in SOD1(G86R); Htr2b −/− mice (Fig. 5c) , suggesting that the loss of Htr2b was associated with degeneration of mononuclear phagocytes in end stage SOD1(G86R) mice. To determine whether this degeneration of mononuclear phagocytes affected microglia and/or monocytes, we measured expression levels of genes known to be part of the homeostatic microglial signature [7] [8] [9] 12] , in particular Cx3cr1, Hexb, Tmem119, P2ry12, Olflm3 and SiglecH. All these genes displayed lower expression in SOD1(G86R) mice lacking the Htr2b gene than in SOD1(G86R) mice with the Htr2b gene (Fig. 6) . The establishment of the homeostatic microglial signature is dependent upon TGFß and Tgfbr1, the microglial receptor of TGFß [8] . Consistent with previous work, we observed induction of TGFß and its receptor in SOD1(G86R) mice [24] , and these two inductions were blunted in SOD1(G86R) mice lacking the Htr2b gene (Fig. 6b) . Importantly expression levels of Ly6c1, a cell surface marker expressed on monocytes, but not microglia [9] , were unaltered in SOD1(G86R) mice, irrespective of the Htr2b genotype (Fig. 6c) . To define the relationships between 5-HT 2B R and microglial survival, we stimulated primary microglial cultures with 5-HT 2B R-targeted drugs. We selected 5-HT 2B R ligands classically used to target the 5-HT 2B R, in particular SB204741, a fairly selective antagonist of the 5-HT 2B R with 50 fold selectivity for 5-HT 2B R over other type 2 serotonin receptors, BW723C86, a preferential 5-HT 2B R agonist, with 50 fold selectivity for 5-HT 2B R over other type 2 serotonin receptors, and SB206553, an inverse agonist of both 5-HT 2B /5-HT 2C Rs [2, 43] . Microglial viability was decreased after 48 h in the presence of 1 µM of SB204741 (Fig. 7a) , and increased in the presence of 3 µM of BW723C86. There was consistently more LDH (Fig. 7b) . To determine whether the 5-HT 2B R could also modulate microglial gene expression beyond survival, we measured mRNA levels of genes strongly modulated by Htr2b genotype in SOD1(G86R) mice (Fig. 4d) in primary microglia treated with 5-HT 2B R drugs and/or lipopolysaccharide (LPS) as a neuroinflammatory stimulus. 5-HT 2B R pharmacological modulation was not sufficient to alter the expression levels of Nox2, Ym1, Mhc2 or Trem2 whether in the absence or presence of LPS for 48 h (Fig. 7c) . Thus, acute modulation of 5-HT 2B R modifies survival of primary microglia, but does not affect-neuroinflammatory gene expression. Taken together, our results indicate that 5-HT 2B R actively promotes microglial survival during neurodegeneration.
HTR2B polymorphisms associated with differential levels of 5-HT 2B R mRNA affect morphology of mononuclear phagocytes and survival in ALS Next, we studied whether the HTR2B gene was a modifier of ALS. To this end, we interrogated genome wide association study (GWAS) results of 1886 ALS cases and 2752 controls of Dutch origin. In these samples, we identified seven different intronic SNPs. None of these SNPs showed differential frequencies between cases and controls, showing that at least in this Dutch population HTR2B polymorphisms are not a risk factor for ALS. However, a significant association with survival was found for SNP rs10199752 as a prototypical example of these highly correlated SNPs. We isolated patients in whom all phenotype data were available (Table S1) , and used a dominant Fig. 6 The ablation of Htr2b in SOD1 (G86R) mice decreases expression of homeostatic microglia genes, while not affecting monocyte marker Ly6c1. a-c mRNA levels of the genes typical of the homeostatic microglia signature (a), TGFß pathway (b), and of Ly6c1, a monocyte marker, in brainstem of SOD1(G86R) mice wild type for Htr2b (+/+ red columns) or knock-out for Htr2b (−/− blue columns) relative to wild type mice (Wt, black columns). *p < 0.05, **p < 0.01; ***p < 0.001 One way ANOVA followed by Tukey post hoc test. N = 7 , that releases all LDH contained in cells after subtracting the value of untreated cells. Note that treatment with BW723C86 (5-HT 2B agonist) leads to decrease in basal LDH release, leading to negative values. ***p < 0.001; *p < 0.05 as indicated by brackets; One way ANOVA followed by Tukey post hoc test. The experiments were performed in triplicate in three independent experiments. c mRNA levels of the indicated genes in primary mouse microglia incubated with 3 µM of BW723C86 (5-HT 2B agonist), 1 µM of SB204741 (5-HT 2B antagonist), 3 µM of SB206553 (5-HT 2B inverse agonist) relative to vehicle (DMSO) with or without 1 µg/ml LPS for 48 h. mRNA levels are given in % of control. Data are presented as mean ± SEM of n = 3-5 experiments ***p < 0.001 significantly different (One-way ANOVA followed by Tukey post hoc test) model to compare the survival of the variant group (combined genotypes C/A and C/C, n = 918) with the wild type homozygous reference group (A/A, n = 759). This analysis revealed that patients with the variant genotypes have a longer survival time compared to the homozygous reference group (hazard ratio = 0.88; confidence interval 0.79-0.98; p value = 0.019) (Fig. 8a) . To determine whether HTR2B polymorphisms were associated with changes in HTR2B expression levels, we genotyped a cohort of autopsied ALS patients (Table S2) . In this cohort, 6 patients carried an A/A genotype, and 10 patients carried a C/A genotype. There was no patient with the C/C genotype. In patients who carried the C/A genotype of rs10199752, we observed decreased spinal cord HTR2B mRNA levels as compared with patients carrying the A/A genotype of rs10199752 (Fig. 8b) . We then performed Iba1 immunohistochemistry on lumbar spinal cord sections of these same patients and conducted a semi-quantitative evaluation of the degeneration of Iba1-positive cells (Fig. 8c) . Notably, degenerating Iba1-positive cells-as evidenced by the presence of fragmented and/or beaded processes-were frequently observed in patients with the A/A genotype of rs10199752 (Fig. 8d , arrows in lower panels), but much less frequently in patients with the C/A genotype (Fig. 8d, upper panels) . Quantification revealed more frequent and severe degeneration of spinal cord Iba1 positive cells in patients with the A/A genotype than in patients with the C/A genotype (Fig. 8c) . As a whole, HTR2B polymorphisms associated with higher spinal cord mRNA levels were also associated with increased survival and less pronounced degeneration of mononuclear phagocytes.
Discussion
Our current study provides multiple lines of evidence supporting that the 5-HT 2B R is a disease modifier of ALS progression by regulating survival and function of mononuclear phagocytes during neurodegeneration.
Our first important result is that HTR2B expression levels affect ALS progression, both in patients and in a transgenic mouse model. Htr2b ablation did not modify disease onset, but sharply accelerated disease progression in mutant SOD1 mice. The effect was observed despite compound transgenic mice were generated in the mixed FVB/N × 129 Sv background. The background was identical in all mice, as we used the F1 generation littermates to generate the F2 generation of interest. Interestingly, as illustrated in Fig. 2c , the mixed background increased overall survival of SOD1(G86R) mice and increased heterogeneity in survival. This effect of mixed genetic background has been previously reported, including by us [30, 38] . Accelerated death of mutant SOD1 mice ablated of Htr2b was due to accelerated neurodegeneration, and not to potential confounding effects on cardiac patho-physiology. Consistently, ALS patients carrying common haplotypes associated with higher spinal cord HTR2B mRNA expression levels survived longer than patients with low expression haplotypes. The relationship between HTR2B polymorphisms and survival will have to be investigated in larger cohorts, and different genetic backgrounds, but constitutes an example of a common polymorphism modifying disease progression but not disease risk. An interesting open question is whether HTR2B might affect other phenotypes associated with ALS. It is conceivable that HTR2B modulates the development of frontal symptoms commonly associated with ALS [64] . Indeed, Htr2b −/− mice were recently shown to display deficits in social interactions, as well as in learning and memory processes [59] , and these processes require intact frontal lobe function. Along the same lines, the Q20* polymorphism, only found in the Finnish population, is associated with severe impulsivity [3] , possibly caused by frontal lobe degeneration. Further work is thus required to elucidate the extent of the contribution of HTR2B in ALS-associated phenotypes, in particular in relation with frontal symptoms.
The second major result is that 5-HT 2B R could regulate morphology and function of central nervous mononuclear phagocytes, including microglia, in ALS. Here again we provide multiple complementary lines of evidence. Abnormalities of mononuclear phagocytes include (i) decreased overall Iba1 immunostaining, (ii) decreased induction of multiple pro-or anti-inflammatory genes, and (iii) fragmentation of Iba1-positive cells. A reasonable mechanism underlying all these different observations would be that 5-HT 2B R function is critical for survival of mononuclear phagocytes during prolonged neuroinflammation such as occurs in ALS. Survival of primary microglia was improved by 5-HT 2B R stimulation and decreased by its inhibition, consistent with previous work showing a protective function of 5-HT 2B R in newborn cardiomyocytes [54] . These studies will have to be extended to adult spinal cord microglia to determine the effect of aging, as well as the potential role of microglial location in their response to 5-HT 2B R stimulation. Our current work does not formally determine whether degenerating Iba1-positive cells are microglia and/ or infiltrating monocytes. The extent of monocyte infiltration remains controversial in the field of ALS [1, 9, 12, 46, 50] , contrary to Alzheimer's disease in which monocyte infiltration has been repeatedly observed [31, 32] . Our gene expression results demonstrate consistent loss of expression of multiple genes typical of homeostatic microglia while the monocyte marker Ly6c1 remained unaffected (Fig. 6 ). Such loss of homeostatic microglial gene expression in whole tissue could be due to cell loss, leading to decreased proportion of microglial mRNAs. Alternatively, disease progression could also affect microglial phenotype, and a recent study performed on isolated microglia of mutant SOD1 mice observed that mutant SOD1 microglia lost their typical expression patterns with disease progression [7] . However, our in vitro experiments provide an initial proof of concept that microglial survival could be influenced by serotonergic stimulation of the 5-HT 2B R. Further work is required to determine the relative contributions of microglial cell death and altered microglial phenotypes in the observed degenerative phenotype in vivo as well as the importance of monocyte degeneration. Interestingly, degeneration of mononuclear phagocytes is commonly associated with human neurodegenerative diseases, and commonly referred to as microglial degeneration [63] , whereas rodent models appear less affected by this phenotype. However, previous studies observed degeneration of mononuclear phagocytes in a transgenic mutant SOD1 rat [25] , similar to our current results in mutant SOD1 mice carrying a wild type Htr2b gene. Loss of Htr2b almost doubled the proportion of fragmented Iba1-positive cells, showing the importance of this receptor in preventing phagocyte degeneration during disease, although detailed molecular pathways remain to be elucidated.
The processes underlying degeneration of mononuclear phagocytes during ALS remain elusive, and the relationships between microglial activation, for instance through inflammasomes [70] , and microglial survival are not understood. Paradoxically, Trem2 was found to be upregulated in SOD1(G86R) mice in the absence of Htr2b. Trem2 is a scavenger receptor found on the surface of myeloid cells, and TREM2 mutations leading to impaired phagocytic activity [42] are strong risk factors for multiple neurodegenerative diseases, including ALS [10, 27, 39] . Whether increased expression of Trem2 in SOD1(G86R); Htr2b −/− mice is beneficial or deleterious remains unknown. However, recent work demonstrated that loss of Trem2 leads either to microglial degeneration in different diseases of the central nervous system [11, 60, 71] , or conversely to protection [37] . Thus, the exact mechanisms underlying 5-HT 2B R-mediated regulation of microglial survival and the role of scavenger receptors in this response will have to be investigated in further studies.
A major question arising from our work is whether the lack of 5-HT 2B R accelerates ALS progression through its effects on degeneration of mononuclear phagocytes. The hypothesis that degeneration of mononuclear phagocytes is directly linked to the lack of 5-HT 2B R in this cell type is plausible for several reasons. First, Htr2b expression has been detected in newborn brain microglia [44] although it remains low in basal conditions [7, 8, 12, 33] . Htr2b is also highly expressed in peripheral macrophages [14] . Htr2b expression was restricted to CD11b-positive cells purified from spinal cord and brainstem, thus originating from mononuclear phagocytes, either microglia or infiltrating monocytes. Second, the late occurrence of Htr2b upregulation [15] coincides with activation of mononuclear phagocytes in SOD1(G86R) mice. Third, the effects of Htr2b ablation on ALS progression are strikingly similar to interventions performed on mononuclear phagocytes. For instance, knocking out mutant SOD1 or NF-kappaB signaling from CD11b-positive cells improved disease progression, but had no effect on disease onset [5, 26] . Despite these parallels, our current results cannot exclude that at least part of the effects of Htr2b ablation are caused by its expression in other cell types. Besides mononuclear phagocytes, Htr2b is expressed at detectable levels in serotonergic neurons themselves [16] , and is known to regulate serotonin release [2, 17] . It is therefore possible that the observed decrease in weight in SOD1(G86R) mice devoid of the Htr2b gene was due to serotonergic neurons indirectly affecting hypothalamic circuitry, consistent with our recent results (Vercruysse et al., Brain, in press). To date, no conditional knock-out model of Htr2b gene has been characterized. Thus, the current knowledge of the function of Htr2b in microglial cells remains limited to in vitro studies (this study (Fig. 7) or previous results [44] ). The generation and characterization of knockout mice in which Htr2b deletion is restricted to microglia will yield invaluable insights into this question.
To our knowledge, these results provide the first genetic evidence for an involvement of the serotoninergic system in ALS. We previously showed that platelet serotonin content correlated with survival [22] . Brain-derived serotonin was decreased in ALS patients and mice [15] , and imaging studies consistently report dramatic reduction in the binding of 5-HT 1A ligand [66, 67] . Pharmacological interventions targeting serotonin provided some evidence for its involvement. For instance, perinatally administered fluoxetine accelerated weight loss and disease onset in ALS rats [45] , while 5-hydroxytryptophan, the serotonin precursor, delayed disease in mutant SOD1 mice [65] . Furthermore, spasticity appears linked to serotonergic abnormalities [15] . Here we provide genetic evidence that the serotonin system is involved in disease progression and microglial function. The observation that lack of Htr2b accelerated weight loss in ALS mice raises questions on the role of serotonin in weight loss during ALS progression [21] , and our most recent results show that loss of serotonin is involved in the development of melanocortin defects (Vercruysse et al., Brain, in press).
Collectively, our results suggest that the 5-HT 2B R might be an interesting target to prolong survival of ALS patients after onset. However, this should be tempered by the known cardiovascular side effects of 5-HT 2B R agonists. Chronic use of 5-HT 2B R agonists has been associated with cardiac valvulopathies and pulmonary hypertension [36] , and a therapeutic strategy targeting 5-HT 2B R should consider the balance between potential benefits and cardiovascular risks in a currently intractable and rapidly progressive disease like ALS, in which patients are most often in good cardiovascular health. Since we identify common HTR2B polymorphisms as differentially associated with HTR2B expression in the CNS, eventual clinical studies should also take into account HTR2B genetic variations.
